Cargando…

FAS Prevention Strategies: Passive and Active Measures

FAS prevention programs attempt to reduce the incidence of drinking during pregnancy by educating women about the risks of alcohol to their unborn babies. Alcoholic beverage warning labels reach a wide audience and have had some effect on curtailing such drinking. Community-based efforts, however, r...

Descripción completa

Detalles Bibliográficos
Autor principal:	Hankin, Janet R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Institute on Alcohol Abuse and Alcoholism 1994
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876477/ https://www.ncbi.nlm.nih.gov/pubmed/31798135

Ejemplares similares

Fetal Alcohol Syndrome Prevention Research
por: Hankin, Janet R.
Publicado: (2002)

Passive and Active Vaccination Strategies to Prevent Ricin Poisoning
por: Pincus, Seth H., et al.
Publicado: (2011)

Fas and Fas Ligand Interactions Suppress Melanoma Lung Metastasis
por: Owen-Schaub, Laurie B., et al.
Publicado: (1998)

Membrane-bound but not Secreted Fas Ligand Is Essential for Fas-Induced Apoptosis and Prevention of Autoimmunity and Cancer
por: O' Reilly, Lorraine A., et al.
Publicado: (2009)

The extracellular domains of FasL and Fas are sufficient for the formation of supramolecular FasL-Fas clusters of high stability
por: Henkler, Frank, et al.
Publicado: (2005)

Selective activation of Fas/Fas ligand-mediated cytotoxicity by a self peptide
Publicado: (1996)

Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids
Publicado: (1995)

Fas/FasL and Complement Activation are Associated with Chronic Active Epstein-Barr Virus Hepatitis
por: Lin, Jing, et al.
Publicado: (2023)

Evaluation of the Effectiveness of Active and Passive Safety Measures in Preventing Ship–Bridge Collision
por: Ma, Wenqing, et al.
Publicado: (2022)

Activation of the Fas/Fas ligand pathway in hypertensive renal disease in Dahl/Rapp rats
por: Sanders, Paul W, et al.
Publicado: (2002)

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand
Publicado: (1996)

Differential expressions of Fas and Fas ligand in human placenta.
por: Roh, Cheong-Rae, et al.
Publicado: (2002)

Soluble Fas and the −670 Polymorphism of Fas in Lupus Nephritis
por: Bollain-y-Goytia, Juan José, et al.
Publicado: (2014)

The Fas/FasL System in Reproduction: Survival and Apoptosis
por: Mor, Gil, et al.
Publicado: (2002)

Novel Fas-TNFR chimeras that prevent Fas ligand-mediated kill and signal synergistically to enhance CAR T cell efficacy
por: McKenzie, Callum, et al.
Publicado: (2023)

Osteocalcin triggers Fas/FasL-mediated necroptosis in adipocytes via activation of p300
por: Otani, Takahito, et al.
Publicado: (2018)

Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus
por: Vincent, Fabien B, et al.
Publicado: (2020)

Understanding the role of Fas-Fas ligand system in bone
por: Marusic, Ana, et al.
Publicado: (2012)

Apoptosis role of FAS/FAS ligand system in the regulation of myelopoiesis.
por: Alenzi, Faris Q., et al.
Publicado: (2005)

Strategies for active and passive pediatric RSV immunization
por: Eichinger, Katherine M., et al.
Publicado: (2021)

Tracking the Prevalence of FAS
por: Cordero, José F., et al.
Publicado: (1994)

Fas-activated serine/threonine kinase (FAST) phosphorylates TIA-1 during Fas-mediated apoptosis
Publicado: (1995)

Activation of Fas/FasL pathway and the role of c-FLIP in primary culture of human cholangiocarcinoma cells
por: Carnevale, Gianluca, et al.
Publicado: (2017)

Strategies for Control of Pandemic Influenza: Active and Passive Immunization
por: Nguyen, Huan H.
Publicado: (2011)

Role of the Fas/FasL pathway in HIV or SIV disease
por: Poonia, Bhawna, et al.
Publicado: (2009)

Prognostic value of the Fas/Fas ligand system in breast cancer
por: Bębenek, Marek, et al.
Publicado: (2013)

Fas–Fas Ligand: Checkpoint of T Cell Functions in Multiple Sclerosis
por: Volpe, Elisabetta, et al.
Publicado: (2016)

Targeting IL-6 by both passive or active immunization strategies prevents bleomycin-induced skin fibrosis
por: Desallais, Lucille, et al.
Publicado: (2014)

FAS and FAS-Ligand Promoter Polymorphisms in Hepatitis B Virus Infection
por: Mohammadi, Asadollah, et al.
Publicado: (2015)

The relationship between Fas and Fas ligand gene polymorphism and preeclampsia risk
por: Wang, Tingting, et al.
Publicado: (2019)

Impairment of Fas-ligand–caveolin-1 interaction inhibits Fas-ligand translocation to rafts and Fas-ligand-induced cell death
por: Glukhova, Xenia A., et al.
Publicado: (2018)

The Economic Cost of FAS
por: Bloss, Gregory
Publicado: (1994)

Intervention and the Child With FAS
por: Weiner, Lyn, et al.
Publicado: (1994)

Spontaneous Development of Plasmacytoid Tumors in Mice with Defective Fas–Fas Ligand Interactions
por: Davidson, Wendy F., et al.
Publicado: (1998)

Modulation of SIV and HIV DNA Vaccine Immunity by Fas-FasL Signaling
por: Yan, Jiabin, et al.
Publicado: (2015)

Strategies in megasynthase engineering – fatty acid synthases (FAS) as model proteins
por: Fischer, Manuel, et al.
Publicado: (2017)

Involvement of Fas/FasL pathway in the murine model of atopic dermatitis
por: Bień, Karolina, et al.
Publicado: (2017)

Fas/FasL Contributes to HSV-1 Brain Infection and Neuroinflammation
por: Krzyzowska, Malgorzata, et al.
Publicado: (2021)

Oncolytic Poxvirus Armed with Fas Ligand Leads to Induction of Cellular Fas Receptor and Selective Viral Replication in FasR Negative Cancer
por: Sathaiah, Magesh, et al.
Publicado: (2011)

Plasma concentrations of soluble Fas receptors (Fas) and Fas ligands (FasL) in relation to CD4+ cell counts in HIV-1 positive and negative patients in Yaounde, Cameroon
por: Ikomey, George M, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_jimtdmasgvmdthftip0ke49jga